Theophylline Extended-Release Tablets recalled for dissolution test failure
Glenmark Pharmaceuticals is recalling Theophylline (Anhydrous) Extended-Release Tablets, 600 mg, due to out-of-specification results on dissolution testing. The recall affects 8,520 bottles distributed nationwide.
- Product
- THEOPHYLLINE — THEOPHYLLINE (THEOPHYLLINE)
- Category
- Drug
- Distribution
- Distributed nationwide